Trial intelligence / Profile preview

Post-marketing study of Ogamma 100 (interferon gamma-nl) in adult T-cell leukemia

jRCT1080220042Phase 4

Sponsor
Otsuka Pharmaceutical Co., Ltd.
Start
Sep 2005
Modality
Cytokines & Interferons → Recombinant Proteins and Enzymes
Countries
1
01

Overview

Phase 4, single-arm trial of interferon gamma-1b in adult T-cell leukemia-lymphoma (ATLL), sponsored by Otsuka Pharmaceutical Co., Ltd.

02

Drugs

interferon gamma-1b
03

Conditions

adult T-cell leukemia-lymphoma (ATLL)

Beyond the preview

Go deeper on jRCT1080220042.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on jRCT1080220042.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call